Key Points
Leptomeningeal B cell accumulation is a prominent feature of GME.
Meningeal B cell infiltrates correlate with cortical demyelination as observed in MS.
GME is a natural model to study compartmentalized neuroinflammation as seen in MS.
Abstract
Multiple sclerosis (MS) is an idiopathic demyelinating disease in which meningeal inflammation correlates with accelerated disease progression. The study of meningeal inflammation in MS has been limited because of constrained access to MS brain/spinal cord specimens and the lack of experimental models recapitulating progressive MS. Unlike induced models, a spontaneously occurring model would offer a unique opportunity to understand MS immunopathogenesis and provide a compelling framework for translational research. We propose granulomatous meningoencephalomyelitis (GME) as a natural model to study neuropathological aspects of MS. GME is an idiopathic, progressive neuroinflammatory disease of young dogs with a female bias. In the GME cases examined in this study, the meninges displayed focal and disseminated leptomeningeal enhancement on magnetic resonance imaging, which correlated with heavy leptomeningeal lymphocytic infiltration. These leptomeningeal infiltrates resembled tertiary lymphoid organs containing large B cell clusters that included few proliferating Ki67+ cells, plasma cells, follicular dendritic/reticular cells, and germinal center B cell–like cells. These B cell collections were confined in a specialized network of collagen fibers associated with the expression of the lympho-organogenic chemokines CXCL13 and CCL21. Although neuroparenchymal perivascular infiltrates contained B cells, they lacked the immune signature of aggregates in the meningeal compartment. Finally, meningeal B cell accumulation correlated significantly with cortical demyelination reflecting neuropathological similarities to MS. Hence, during chronic neuroinflammation, the meningeal microenvironment sustains B cell accumulation that is accompanied by underlying neuroparenchymal injury, indicating GME as a novel, naturally occurring model to study compartmentalized neuroinflammation and the associated pathology thought to contribute to progressive MS.
Footnotes
This work was supported by the National Institute of Health through National Institute of Neurological Disorders and Stroke Grant 5K01NS097519-03 (to J.I.A.) and National Center for Advancing Translational Sciences Grant 5UL1TR001878-04 to the Institute of Translational Medicine and Therapeutics and via the Program in Comparative Animal Biology of the University of Pennsylvania (to A.B.-O. and J.I.A.). J.I.A. held the David L. Torrey End MS Transitional Career Development Award from the Multiple Sclerosis Society of Canada.
The online version of this article contains supplemental material.
- Received May 6, 2020.
- Accepted April 23, 2021.
- Copyright © 2021 by The American Association of Immunologists, Inc.